Despite achieving a higher objective response rate (ORR) to initial chemotherapy, the high Ki-67 group is characterized by more aggressive tumor behavior, including a higher prevalence of NEC and distant metastasis. This evidence concerns the gene MKI67 and neuroendocrine carcinoma.